open access

Vol 30, No 4 (2023)
Original Article
Submitted: 2021-06-29
Accepted: 2021-09-30
Published online: 2021-10-25
Get Citation

Time to –30°C as a predictor of acute success during cryoablation in patients with atrial fibrillation

Carlos Antonio Álvarez-Ortega12, Miguel Angel Ruiz3, César Solórzano-Guillén1, Alberto Barrera4, Jorge Toquero-Ramos5, Jesús Daniel Martínez-Alday67, Carlos Grande8, José María Segura9, Arcadio García-Alberola10, Pablo Moriña-Vázquez11, Ángel Ferrero-de-Loma-Osorio1213, Roger Villuendas14, Rocío Cózar1516, Maria Fe Arcocha17, Alicia Ibañez18, Rafael Peinado1
·
Pubmed: 34708863
·
Cardiol J 2023;30(4):534-542.
Affiliations
  1. Arrhythmia Unit, Cardiology Department, University Hospital La Paz, Madrid, Spain
  2. Cardiology Department, University Hospital Torrejón, Spain
  3. School of Psychology. Universidad Autónoma de Madrid, Spain
  4. Hospital Clínico Universitario, Virgen de la V ictoria, Málaga, Spain;
  5. University Hospital Puerta de Hier ro, Majadahonda, Madrid, Spain
  6. Basurto University Hospital, Bilbao, Spain
  7. Clínica IMQ Zorrotzaurre, Bilbao, Spain
  8. Hospital Universitario Son Espases, Palma, Spain
  9. Córdoba Hospital Universitario Reina Sofía, Córdoba, Spain
  10. Department of Cardiology, Hospital Universitario Virgen de la Ar rixaca, Murcia, Spain
  11. Juan Ramón Jiménez Hospital, Huelva, Spain
  12. HospitHospital Clínico Universitario de Valencia, Valencia, Spain
  13. Hospital Quiron Valencia, Valencia, Spain
  14. Hospital Universitario Germans Trias i Pujol, Badalona, Spain
  15. Hospital Universitario Vírgen Macarena, Sevilla, Spain
  16. Hospital Nisa Aljarafe, Sevilla, Spain
  17. Araba Hospital, Vitoria, Spain
  18. Alicante University Genaral Hospital, Alicante, Spain

open access

Vol 30, No 4 (2023)
Original articles — Interventional cardiology
Submitted: 2021-06-29
Accepted: 2021-09-30
Published online: 2021-10-25

Abstract

Background: Freezing rate of second-generation cryoballoon (CB) is a biophysical parameter that
could assist pulmonary vein isolation. The aim of this study is to assess freezing rate (time to reach
–30°C ([TT-30C]) as an early predictor of acute pulmonary vein isolation using the CB.

Methods: Biophysical data from CB freeze applications within a multicenter, nation-wide CB ablation
registry were gathered. Successful application (SA), was defined as achieving durable intraprocedural vein
isolation. And SA with time to isolation under 60 s (SA-TTI<60) as achieving durable vein isolation in
under 60 s. Logistic regressions were performed and predictive models were built for the data set.

Results: 12,488 CB applications from 1,733 atrial fibrillation (AF) ablation procedures were included
within 27 centers from a Spanish CB AF ablation registry. SA was achieved in 6,349 of 9,178 (69.2%)
total freeze applications, and SA-TTI<60 was obtained in 2,673 of 4,784 (55.9%) freezes where electrogram
monitoring was present. TT-30C was shorter in the SA group (33.4 ± 9.2 vs 39.3 ± 12.1 s;
p < 0.001) and SA-TTI<60 group (31.8 ± 7.6 vs. 38.5 ± 11.5 s; p < 0.001). Also, a 10 s increase in
TT-30C was associated with a 41% reduction in the odds for an SA (odds ratio [OR] 0.59; 95% confidence
interval [CI] 0.56–0.63) and a 57% reduction in the odds for achieving SA-TTI<60 (OR 0.43;
95% CI 0.39–0.49), when corrected for electrogram visualization, vein position, and application order.

Conclusions: Time to reach –30°C is an early predictor of the quality of a CB application and can be
used to guide the ablation procedure even in the absence of electrogram monitoring.

Abstract

Background: Freezing rate of second-generation cryoballoon (CB) is a biophysical parameter that
could assist pulmonary vein isolation. The aim of this study is to assess freezing rate (time to reach
–30°C ([TT-30C]) as an early predictor of acute pulmonary vein isolation using the CB.

Methods: Biophysical data from CB freeze applications within a multicenter, nation-wide CB ablation
registry were gathered. Successful application (SA), was defined as achieving durable intraprocedural vein
isolation. And SA with time to isolation under 60 s (SA-TTI<60) as achieving durable vein isolation in
under 60 s. Logistic regressions were performed and predictive models were built for the data set.

Results: 12,488 CB applications from 1,733 atrial fibrillation (AF) ablation procedures were included
within 27 centers from a Spanish CB AF ablation registry. SA was achieved in 6,349 of 9,178 (69.2%)
total freeze applications, and SA-TTI<60 was obtained in 2,673 of 4,784 (55.9%) freezes where electrogram
monitoring was present. TT-30C was shorter in the SA group (33.4 ± 9.2 vs 39.3 ± 12.1 s;
p < 0.001) and SA-TTI<60 group (31.8 ± 7.6 vs. 38.5 ± 11.5 s; p < 0.001). Also, a 10 s increase in
TT-30C was associated with a 41% reduction in the odds for an SA (odds ratio [OR] 0.59; 95% confidence
interval [CI] 0.56–0.63) and a 57% reduction in the odds for achieving SA-TTI<60 (OR 0.43;
95% CI 0.39–0.49), when corrected for electrogram visualization, vein position, and application order.

Conclusions: Time to reach –30°C is an early predictor of the quality of a CB application and can be
used to guide the ablation procedure even in the absence of electrogram monitoring.

Get Citation

Keywords

cryoballoon ablation, second-generation cryoballoon, pulmonary vein isolation, atrial fibrillation, atrial fibrillation ablation

About this article
Title

Time to –30°C as a predictor of acute success during cryoablation in patients with atrial fibrillation

Journal

Cardiology Journal

Issue

Vol 30, No 4 (2023)

Article type

Original Article

Pages

534-542

Published online

2021-10-25

Page views

2274

Article views/downloads

490

DOI

10.5603/CJ.a2021.0135

Pubmed

34708863

Bibliographic record

Cardiol J 2023;30(4):534-542.

Keywords

cryoballoon ablation
second-generation cryoballoon
pulmonary vein isolation
atrial fibrillation
atrial fibrillation ablation

Authors

Carlos Antonio Álvarez-Ortega
Miguel Angel Ruiz
César Solórzano-Guillén
Alberto Barrera
Jorge Toquero-Ramos
Jesús Daniel Martínez-Alday
Carlos Grande
José María Segura
Arcadio García-Alberola
Pablo Moriña-Vázquez
Ángel Ferrero-de-Loma-Osorio
Roger Villuendas
Rocío Cózar
Maria Fe Arcocha
Alicia Ibañez
Rafael Peinado

References (14)
  1. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021; 42(5): 373–498.
  2. Chen S, Schmidt B, Bordignon S, et al. Atrial fibrillation ablation using cryoballoon technology: Recent advances and practical techniques. J Cardiovasc Electrophysiol. 2018; 29(6): 932–943.
  3. Su W, Kowal R, Kowalski M, et al. Best practice guide for cryoballoon ablation in atrial fibrillation: The compilation experience of more than 3000 procedures. Heart Rhythm. 2015; 12(7): 1658–1666.
  4. Su W, Aryana A, Passman R, et al. Cryoballoon Best Practices II: Practical guide to procedural monitoring and dosing during atrial fibrillation ablation from the perspective of experienced users. Heart Rhythm. 2018; 15(9): 1348–1355.
  5. Ciconte G, Mugnai G, Sieira J, et al. On the quest for the best freeze: predictors of late pulmonary vein reconnections after second-generation cryoballoon ablation. Circ Arrhythm Electrophysiol. 2015; 8(6): 1359–1365.
  6. Ciconte G, Velagić V, Mugnai G, et al. Electrophysiological findings following pulmonary vein isolation using radiofrequency catheter guided by contact-force and second-generation cryoballoon: lessons from repeat ablation procedures. Europace. 2016; 18(1): 71–77.
  7. Aryana A, Mugnai G, Singh SM, et al. Procedural and biophysical indicators of durable pulmonary vein isolation during cryoballoon ablation of atrial fibrillation. Heart Rhythm. 2016; 13(2): 424–432.
  8. Andrade J, Champagne J, Dubuc M, et al. Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring. Circulation. 2019; 140(22): 1779–1788.
  9. Ghosh J, Martin A, Keech AC, et al. Balloon warming time is the strongest predictor of late pulmonary vein electrical reconnection following cryoballoon ablation for atrial fibrillation. Heart Rhythm. 2013; 10(9): 1311–1317.
  10. Fürnkranz A, Köster I, Chun KR, et al. Cryoballoon temperature predicts acute pulmonary vein isolation. Heart Rhythm. 2011; 8(6): 821–825.
  11. Ciconte G, Chierchia GB, DE Asmundis C, et al. Spontaneous and adenosine-induced pulmonary vein reconnection after cryoballoon ablation with the second-generation device. J Cardiovasc Electrophysiol. 2014; 25(8): 845–851.
  12. Aryana A, Kenigsberg DN, Kowalski M, et al. Verification of a novel atrial fibrillation cryoablation dosing algorithm guided by time-to-pulmonary vein isolation: Results from the Cryo-DOSING Study (Cryoballoon-ablation DOSING Based on the Assessment of Time-to-Effect and Pulmonary Vein Isolation Guidance). Heart Rhythm. 2017; 14(9): 1319–1325.
  13. Chen S, Schmidt B, Bordignon S, et al. Impact of cryoballoon freeze duration on long-term durability of pulmonary vein isolation: ICE re-map study. JACC Clin Electrophysiol. 2019; 5(5): 551–559.
  14. Chen S, Schmidt B, Bordignon S, et al. Practical Techniques in Cryoballoon Ablation: How to Isolate Inferior Pulmonary Veins. Arrhythm Electrophysiol Rev. 2018; 7(1): 11–17.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl